2m 2m 2m 2m 2m 2m 2m
COGENT BIOSCIS (COGT)
NASDAQ
$36.31+$0.46 (+1.30%)
Price as of Jun 23, 2026 6:41 PM EDT- $6.1BMarket Cap
- 393.66%1-Year Change
- BiotechnologyIndustry
COGENT BIOSCIS (COGT)
$36.31+$0.46 (+1.30%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -269.8M +15.96% | -232.7M +33.90% | -173.8M +42.86% | -121.6M +117.53% | |
Depreciation and Amortization Expense | 2.6M +4.65% | 2.5M +7.93% | 2.3M +169.60% | 842,000 +472.79% | |
Total Operating Expenses | 333.4M +20.81% | 275.9M +32.58% | 208.1M +40.78% | 147.8M +95.68% | |
Operating Profit | -333.4M +20.81% | -275.9M +32.58% | -208.1M +40.78% | -147.8M +95.68% | |
Interest Income | 14.7M -18.79% | 18.1M +38.32% | 13.1M +227.83% | 4.0M +754.18% | |
Interest Expense | -3.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 11.6M -35.93% | 18.1M +38.32% | 13.1M +227.83% | 4.0M +754.18% | |
Total Nonoperating Income and Expense | 4.4M -77.96% | 20.1M +27.74% | 15.7M +106.90% | 7.6M +131.79% | |
Income before Taxes | -333.4M +20.81% | -275.9M +32.58% | -208.1M +40.78% | -147.8M +104.56% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -328.9M +28.56% | -255.9M +32.98% | -192.4M +37.20% | -140.2M +94.04% | |
Net Income from Continuing Operations Applicable to Common | -328.9M +28.56% | -255.9M +32.98% | -192.4M +37.20% | -140.2M +94.04% | |
Basic EPS and Net Income | -538.96 +27,681.44% | -1.94 -19.83% | -2.42 +1.26% | -2.39 +27.81% | |
Diluted EPS and Net Income | -538.96 +27,681.44% | -1.94 -19.83% | -2.42 +1.26% | -2.39 +27.81% | |
Basic Weighted Average Shares | 67,600 -99.93% | 103.9M +30.38% | 79.7M +35.61% | 58.7M +51.66% | |
Diluted Weighted Average Shares | 67,600 -99.93% | 103.9M +30.38% | 79.7M +35.61% | 58.7M +51.66% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 312.0M +217.84% | 98.2M +84.42% | 53.2M -61.95% | 139.9M -36.32% | |
Short-Term Investments | 588.8M +211.65% | 188.9M -11.09% | 212.5M +77.97% | 119.4M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 900.8M +213.77% | 287.1M +8.04% | 265.7M +2.48% | 259.3M +18.02% | |
Total Current Assets | 910.4M +207.06% | 296.5M +9.49% | 270.8M +2.19% | 265.0M +19.01% | |
Accumulated Depreciation | 8.7M +41.93% | 6.1M +66.85% | 3.7M +161.60% | 1.4M +150.63% | |
Property and Plant and Equipment and Net | 5.5M -15.62% | 6.5M -22.50% | 8.3M +7.21% | 7.8M +356.21% | |
Total Long-Term Assets | 3.3M -32.11% | 4.9M -0.04% | 4.9M +2.51% | 4.7M +27.31% | |
Total Assets | 937.6M +185.94% | 327.9M +4.61% | 313.4M +4.20% | 300.8M +29.61% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 64.0M +14.80% | 55.7M +45.96% | 38.2M +42.16% | 26.8M +57.22% | |
Total Long-Term Debt | 222.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 33,000 -99.79% | 15.9M -8.96% | 17.5M -4.16% | 18.2M +2,093.26% | |
Total Liabilities | 301.2M +320.65% | 71.6M +28.72% | 55.6M +23.43% | 45.1M +151.70% | |
Retained Earnings | -1.2B +38.27% | -859.5M +42.39% | -603.6M +46.79% | -411.2M +51.75% | |
Total Stockholders Equity | 636.4M +148.31% | 256.3M -0.59% | 257.8M +0.81% | 255.7M +19.40% | |
Total Shares Outstanding | 161.0M +45.73% | 110.5M +28.26% | 86.1M +23.22% | 69.9M +59.55% | |
Cash Flow | |||||
Cash from Operating Activities | -264.4M +27.26% | -207.8M +35.26% | -153.6M +29.49% | -118.6M +101.89% | |
Capital Expenditures | 1.6M +171.20% | 573,000 -79.51% | 2.8M -59.26% | 6.9M +299.24% | |
Cash from Investing Activities | -399.5M -1,143.80% | 38.3M +139.13% | -97.8M -21.56% | -124.7M +7,155.26% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 878.2M +309.53% | 214.5M +31.13% | 163.5M -0.01% | 163.6M +330.69% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -51.99% -34.85% | -79.79% +27.36% | -62.65% +19.03% | -52.63% +75.88% | |
Return on Equity | -73.70% -25.96% | -99.54% +32.83% | -74.94% +25.55% | -59.69% +85.34% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 14.23 +167.49% | 5.32 -24.99% | 7.09 -28.11% | 9.87 -24.30% | |
Cash Ratio | 4.88 +176.87% | 1.76 +26.35% | 1.39 -73.23% | 5.21 -59.50% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow